1-6 of 6
Zhen Yao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of low-intensity chemotherapy combined with sequential blinatumomab and inotuzumab ozogamicin immunotherapy in newly diagnosed B-ALL patients unfit/fit-declined for intensive chemotherapy: A prospective, open-label, single-arm Phase II trial in progress

Free
Shenhao Liu, Chongsheng Qian, Haiping Dai, Lan Dai, Yanjun Wu, Zhen Yao, Zheng Li, Wenjie Gong, Aining Sun, Depei Wu, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 3358.
https://doi.org/10.1182/blood-2025-3358
Published: 2025
Journal Articles

Auto-HSCT combined with blinatumomab as an allo-HSCT-sparing strategy in newly diagnosed B-ALL: Phase II trial results

Free
Zihao Wang, Chongsheng Qian, Zhen Yao, Zheng Li, Wenjie Gong, Haiping Dai, Yanjun Wu, Kai-Wen Tan, Fangtong Liu, Chao-Ling Wan, Depei Wu, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 3349.
https://doi.org/10.1182/blood-2025-3349
Published: 2025
Journal Articles

Venetoclax, cladribine plus low-dose cytarabine for relapsed/refractory Acute Myeloid Leukemia: A multicenter, randomized phase II Study

Free
Han-Yu Cao, Fangtong Liu, Kai-Wen Tan, Zi-Hao Wang, Si-Man Huang, Chao-Ling Wan, Yuan-Hong Huang, Mei-Jing Liu, Zhen Yao, Zheng Li, Ming-Zhu Xu, Hai-Xia Zhou, Haiping Dai, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 5202.
https://doi.org/10.1182/blood-2025-5202
Published: 2025
Journal Articles

Safety and Efficacy of Blinatumomab and Auto-HSCT “Sandwich” Strategy As Consolidation Therapy for Ph Negative B Cell Acute Lymphoblastic Leukemia

Free
Chong-Sheng Qian, Zihao Wang, Lan Dai, Li Yao, Zhen Yao, HaiXia Zhou, Mingzhu Xu, Wenjie Gong, Zheng Li, Haiping Dai, Aining Sun, Depei Wu, Shengli Xue
Journal: Blood
Blood (2024) 144 (Supplement 1): 5878.
https://doi.org/10.1182/blood-2024-205115
Published: 2024
Journal Articles

Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALL

Free
Liqing Kang, Jinfeng Ma, Xiaoyan Lou, Xiaowen Tang, Shengli Xue, Suning Chen, Huiying Qiu, Miao Miao, Yue Han, Ying Wang, Aining Sun, Haiping Dai, Yang Xu, Limin Li, Shengjin Fan, Chongsheng Qian, Wenjie Gong, Mingzhu Xu, Haixia Zhou, Zhen Yao, Wei Wang, Minghao Li, Nan Xu, Zhou Yu, Depei Wu, Lei Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 889.
https://doi.org/10.1182/blood-2023-172615
Published: 2023
Journal Articles

Phase I Open-Label Single-Arm Study of Sscart-19 in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in China

Free
Liqing Kang, Shengli Xue, Xiaowen Tang, Xiaoyan Lou, Chongsheng Qian, Wenjie Gong, Mingzhu Xu, Haixia Zhou, Zhen Yao, Wei Wang, Minghao Li, Nan Xu, Zhou Yu, Suning Chen, Huiying Qiu, Haiping Dai, Yang Xu, Depei Wu, Lei Yu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3477.
https://doi.org/10.1182/blood-2023-181552
Published: 2023